Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 1.74%
Orchid Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 21, 2024. Further, the company has informed the Exchange regarding voting results along with copy of minutes. | Download
Orchid Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 21, 2024. Further, the company has informed the Exchange regarding voting results along with copy of minutes. | Download
Orchid Pharma Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Orchid Pharma continuesto be on a steady and strong growth trajectory". | Download
Orchid Pharma Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Orchid Pharma continuesto be on a steady and strong growth trajectory". | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant